| http://www.w3.org/ns/prov#value | - The company's proprietary Leumeta(TM) portfolio of tests helps physicians ...Researchers Discover Metabolite Linked to Aggressive Prostate Cancer... was a better indicator of advancing disease than the traditional prostate specific antigen, or PSA, test that is currently used to monitor or screen for prostate cancer.
|
